<DOC>
	<DOCNO>NCT02876692</DOCNO>
	<brief_summary>This prospective cohort study : 1 . First step : establish new score system predication delay graft function ( DGF ) follow kidney transplantation base previous new study data . The new scoring system comprise two part : Xi'an Criteria donor score system kidney evaluation System base Lifeport platform ) . 2 . Second step : validate new score system prospective cohort study transplantation center modify score system need . Recruiting 300 patient , follow day 3 , week 1 , month 1 , month 3 , month 6 month 12 . Patients follow Cr30cl , DGF , primary non-function ( PNF ) , acute rejection ( AR ) , graft survival patient survival 3 . Step 3 : Further validate new score system six transplantation center develop software end . Recruiting 300 patient , follow day 3 , week 1 , month 1 , month 3 , month 6 month 12 . Patients follow Cr30cl , DGF , PGF , AR , graft survival patient survival</brief_summary>
	<brief_title>Prediction Management Delayed Graft Function Based Donor Criteria LifePort Platform</brief_title>
	<detailed_description>Subjects enrol collect data donor recipient . Investigators also collect data recipient donate organ follow : physiological biochemical index , machine perfusion parameter , factor effect renal transplant outcome . A Cox proportional hazard model multiple linear regression analysis apply examine correlation among univariate multivariate . Based analysis improve new score system , Lifeport work platform evaluation system donor kidney quality evaluation system . Then , multi-center clinical trial start improve verify new score system . Finally , donor kidney evaluation APP develop base score system database clinical trial . An applicaiotion ( APP ) popularize national transplant surgeon .</detailed_description>
	<mesh_term>Delayed Graft Function</mesh_term>
	<criteria>Donor 1 . Comply national donation citizen death guideline 2 . No high risk activity : history drug abuse , history intravenous drug use risky sexual behavior 3 . No malignant melanoma , metastatic cancer , incurable cancer ; early stage cancer successful treatment also consider 4 . No activity untreated systemic bacterial , viral fungal infection ; 5 . Patients definitely identify Recipient : 1 . 65 old ≥Age &gt; = 18 year old , male female 2 . BMI＜26 3 . Renal transplantation first time 4 . Not pregnancy lactation , pregnancy test negative , promise pregnant treatment . 5 . Before clinical trial , Patient sign inform consent voluntarily Donor 1 . Older 65 year old 2.Serum hepatitis B virus ( HBV ) , hepatitis C virus ( HCV ) , HIV positive 3.Donor kidney cold storage time 30 hour 4.Warm ischemia time 20 minute 5.Other reagent added perfusion regulation donor renal function Recipient : 1.Involved study . 2.Double organ multiorgan transplant 3.A , B , O blood typeincompatible</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>